The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
SUMO and the robustness of cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
RETRACTED: The E3 SUMO Ligase PIASy Is a Regulator of Cellular Senescence and Apoptosis
Bischof, O., Schwamborn, K., Martin, N., Werner, A., Sustmann, C., Grosschedl, R., & Dejean, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.016 · Cited by 173
Self-citationRetractedUbiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization
Cai, Q., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012636 · Cited by 54
RetractedHigh-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.
Shao, D.-F., Wang, X.-H., Li, Z., Xing, X., Cheng, X., Guo, T., Du, H., Hu, Y. C., Dong, B., Ding, N., et al. (2015) · Europe PMC (PubMed Central) · Cited by 25
RetractedSUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1
Song, J., Xie, H., Li, N., Wu, K., Qiu, J., Shen, D.-M., & Huang, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-3737-z · Cited by 16
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Kitano, H. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1471 · Cited by 2,278
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
Mahajan, R., Delphin, C., Guan, T., Gerace, L., & Melchior, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81862-0 · Cited by 1,256
Matunis, M. J., Coutavas, E., & Blobel, G. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1457 · Cited by 1,197
Sumoylation: A Regulatory Protein Modification in Health and Disease
Flotho, A., & Melchior, F. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061909-093311 · Cited by 1,097
ATM Activation by Oxidative Stress
Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D., & Paull, T. T. (2010) · Science · doi:10.1126/science.1192912 · Cited by 1,079
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3
Saitoh, H., & Hinchey, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6252 · Cited by 895
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M.-C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 847
Non-Cell-Autonomous Tumor Suppression by p53
Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E., Zhao, Z., Thapar, V., Joyce, J. A., Krizhanovsky, V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.020 · Cited by 766
Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 734
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Function and regulation of SUMO proteases
Hickey, C. M., Wilson, N. R., & Hochstrasser, M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3478 · Cited by 638
Senescent cells as a source of inflammatory factors for tumor progression
Davalos, A. R., Coppe, J.-P., Campisi, J., & Desprez, P.-Y. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9220-9 · Cited by 636
SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during Hypoxia
Cheng, J., Kang, X., Zhang, S., & Yeh, E. T. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.045 · Cited by 624
Regulation of DNA Damage Responses by Ubiquitin and SUMO
Jackson, S. P., & Durocher, D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.017 · Cited by 601
Role of SUMO-1–modified PML in nuclear body formation
Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A., & Pandolfi, P. P. (2000) · Blood · doi:10.1182/blood.v95.9.2748.009k31a_2748_2752 · Cited by 561
Self-citationHuang, T. T., Wuerzberger-Davis, S. M., Wu, Z.-H., & Miyamoto, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00895-x · Cited by 560
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., Dessen, P., d’Hayer, B., Mohamdi, H., Remenieras, A., et al. (2011) · Nature · doi:10.1038/nature10539 · Cited by 526
Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks
Galanty, Y., Belotserkovskaya, R., Coates, J., Polo, S., Miller, K. M., & Jackson, S. P. (2009) · Nature · doi:10.1038/nature08657 · Cited by 523
A comprehensive compilation of SUMO proteomics
Hendriks, I. A., & Vertegaal, A. C. O. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.81 · Cited by 514
System-Wide Changes to SUMO Modifications in Response to Heat Shock
Golebiowski, F., Matic, I., Tatham, M. H., Cole, C., Yin, Y., Nakamura, A., Cox, J., Barton, G. J., Mann, M., & Hay, R. T. (2009) · Science Signaling · doi:10.1126/scisignal.2000282 · Cited by 485
Protein Group Modification and Synergy in the SUMO Pathway as Exemplified in DNA Repair
Psakhye, I., & Jentsch, S. (2012) · Cell · doi:10.1016/j.cell.2012.10.021 · Cited by 484
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
Yokoyama, S., Woods, S. L., Boyle, G. M., Aoude, L. G., MacGregor, S., Zismann, V., Gartside, M., Cust, A. E., Haq, R., Harland, M., et al. (2011) · Nature · doi:10.1038/nature10630 · Cited by 484
Regulation of gene-activation pathways by PIAS proteins in the immune system
Shuai, K., & Liu, B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1667 · Cited by 447
Modification with SUMO: A role in transcriptional regulation
Verger, A., Perdomo, J., & Crossley, M. (2003) · EMBO reports · doi:10.1038/sj.embor.embor738 · Cited by 440
A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
Kessler, J. D., Kahle, K. T., Sun, T., Meerbrey, K. L., Schlabach, M. R., Schmitt, E. M., Skinner, S. O., Xu, Q., Li, M. Z., Hartman, Z. C., et al. (2012) · Science · doi:10.1126/science.1212728 · Cited by 433
Ionizing radiation induces expression and binding activity of the nuclear factor kappa B.
Brach, M. A., Hass, R., Sherman, M. L., Gunji, H., Weichselbaum, R., & Kufe, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115354 · Cited by 408
Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress
Bassi, C., Ho, J., Srikumar, T., Dowling, R. J. O., Gorrini, C., Miller, S. J., Mak, T. W., Neel, B. G., Raught, B., & Stambolic, V. (2013) · Science · doi:10.1126/science.1236188 · Cited by 403
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 398
Regulation of SUMOylation by Reversible Oxidation of SUMO Conjugating Enzymes
Bossis, G., & Melchior, F. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.12.019 · Cited by 391
Evolution and functional cross‐talk of protein post‐translational modifications
Beltrao, P., Bork, P., Krogan, N. J., & van Noort, V. (2013) · Molecular Systems Biology · doi:10.1002/msb.201304521 · Cited by 380
The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress
Morris, J. R., Boutell, C., Keppler, M., Densham, R., Weekes, D., Alamshah, A., Butler, L., Galanty, Y., Pangon, L., Kiuchi, T., et al. (2009) · Nature · doi:10.1038/nature08593 · Cited by 375
Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate
Fukuda, I., Ito, A., Hirai, G., Nishimura, S., Kawasaki, H., Saitoh, H., Kimura, K.-I., Sodeoka, M., & Yoshida, M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.009 · Cited by 355
Sternsdorf, T., Jensen, K., & Will, H. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1621 · Cited by 331
Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G. K., Holsboer, F., & Arzt, E. (2007) · Cell · doi:10.1016/j.cell.2007.07.044 · Cited by 318
RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair
Galanty, Y., Belotserkovskaya, R., Coates, J., & Jackson, S. P. (2012) · Genes & Development · doi:10.1101/gad.188284.112 · Cited by 314
Ubc9- and Mms21-Mediated Sumoylation Counteracts Recombinogenic Events at Damaged Replication Forks
Branzei, D., Sollier, J., Liberi, G., Zhao, X., Maeda, D., Seki, M., Enomoto, T., Ohta, K., & Foiani, M. (2006) · Cell · doi:10.1016/j.cell.2006.08.050 · Cited by 291
SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer
Eifler, K., & Vertegaal, A. C. O. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.09.006 · Cited by 290
SUMO: A Multifaceted Modifier of Chromatin Structure and Function
Cubeñas-Potts, C., & Matunis, M. J. (2013) · Developmental Cell · doi:10.1016/j.devcel.2012.11.020 · Cited by 281
Senescent cells develop a parp-1 and nuclear factor-κB-associated secretome (PNAS).
Ohanna, M., Giuliano, S., Bonet, C., Imbert, V., Hofman, V., Zangari, J., Bille, K., Robert, C., Bressac-de Paillerets, B., Hofman, P., et al. (2011) · Genes & Development · doi:10.1101/gad.625811 · Cited by 267
Epithelial-Mesenchymal Transition Induced by Senescent Fibroblasts
Laberge, R.-M., Awad, P., Campisi, J., & Desprez, P.-Y. (2012) · Cancer Microenvironment · doi:10.1007/s12307-011-0069-4 · Cited by 255
DNA damage‐dependent NF‐κB activation: NEMO turns nuclear signaling inside out
McCool, K. W., & Miyamoto, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01101.x · Cited by 250
Li, J., Xu, Y., Long, X.-D., Wang, W., Jiao, H.-K., Mei, Z., Yin, Q.-Q., Ma, L.-N., Zhou, A.-W., Wang, L.-S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.008 · Cited by 242
Deciphering a global network of functionally associated post‐translational modifications
Minguez, P., Parca, L., Diella, F., Mende, D. R., Kumar, R., Helmer‐Citterich, M., Gavin, A., van Noort, V., & Bork, P. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.31 · Cited by 233
A nuclear poly(ADP-Ribose)-dependent signalosome confers DNA damage-induced IκB kinase activation.
Stilmann, M., Hinz, M., Arslan, S. Ç., Zimmer, A., Schreiber, V., & Scheidereit, C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.032 · Cited by 232
SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia
Guo, C., Hildick, K. L., Luo, J., Dearden, L., Wilkinson, K. A., & Henley, J. M. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.65 · Cited by 226
PIASy mediates NEMO sumoylation and NF-κB activation in response to genotoxic stress
Mabb, A. M., Wuerzberger-Davis, S. M., & Miyamoto, S. (2006) · Nature Cell Biology · doi:10.1038/ncb1458 · Cited by 226
Gill, G. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00021-2 · Cited by 226
C-terminal modifications regulate MDM2 dissociation and nuclear export of p53
Carter, S., Bischof, O., Dejean, A., & Vousden, K. H. (2007) · Nature Cell Biology · doi:10.1038/ncb1562 · Cited by 225
Self-citationUbc9 Sumoylation Regulates SUMO Target Discrimination
Knipscheer, P., Flotho, A., Klug, H., Olsen, J. V., van Dijk, W. J., Fish, A., Johnson, E. S., Mann, M., Sixma, T. K., & Pichler, A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.022 · Cited by 221
SUMOylation promotes de novo targeting of HP1α to pericentric heterochromatin
Maison, C., Bailly, D., Roche, D., de Oca, R. M., Probst, A. V., Vassias, I., Dingli, F., Lombard, B., Loew, D., Quivy, J.-P., et al. (2011) · Nature Genetics · doi:10.1038/ng.765 · Cited by 211
SENP3 is responsible for HIF‐1 transactivation under mild oxidative stress via p300 de‐SUMOylation
Huang, C., Han, Y., Wang, Y., Sun, X., Yan, S., Yeh, E. T. H., Chen, Y., Cang, H., Li, H., Shi, G., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.210 · Cited by 207
Huang, J., Yan, J., Zhang, J., Zhu, S., Wang, Y., Shi, T., Zhu, C., Chen, C., Liu, X., Cheng, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1919 · Cited by 200
Spatiotemporal regulation of posttranslational modifications in the DNA damage response
Dantuma, N. P., & van Attikum, H. (2016) · The EMBO Journal · doi:10.15252/embj.201592595 · Cited by 200
SUMO-1/Ubc9 Promotes Nuclear Accumulation and Metabolic Stability of Tumor Suppressor Smad4
Lin, X., Liang, M., Liang, Y.-Y., Brunicardi, F. C., & Feng, X.-H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300112200 · Cited by 189
Redox Sensing by Proteins: Oxidative Modifications on Cysteines and the Consequent Events
Wang, Y., Yang, J., & Yi, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4313 · Cited by 188
Comerford, K. M., Leonard, M. O., Karhausen, J., Carey, R., Colgan, S. P., & Taylor, C. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337412100 · Cited by 185
Sumoylation of Smad4, the Common Smad Mediator of Transforming Growth Factor-β Family Signaling
Lee, P. S. W., Chang, C., Liu, D., & Derynck, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301755200 · Cited by 183
The relevance of the TGF-β Paradox to EMT-MET programs
Morrison, C. D., Parvani, J. G., & Schiemann, W. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.048 · Cited by 183
Buscà, R., Berra, E., Gaggioli, C., Khaled, M., Bille, K., Marchetti, B., Thyss, R., Fitsialos, G., Larribère, L., Bertolotto, C., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501067 · Cited by 178
Taylor, K. M., & LaBonne, C. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.016 · Cited by 175
Ling, Y., Sankpal, U. T., Robertson, A. K., McNally, J. G., Karpova, T., & Robertson, K. D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh195 · Cited by 164
Agricola, E., Randall, R. A., Gaarenstroom, T., Dupont, S., & Hill, C. S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.020 · Cited by 158
A sumoylation site in PML/RARA is essential for leukemic transformation
Zhu, J., Zhou, J., Peres, L., Riaucoux, F., Honoré, N., Kogan, S., & de Thé, H. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.005 · Cited by 158
Frequent mutations in the MITF pathway in melanoma
Cronin, J. C., Wunderlich, J., Loftus, S. K., Prickett, T. D., Wei, X., Ridd, K., Vemula, S., Burrell, A. S., Agrawal, N. S., Lin, J. C., et al. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00578.x · Cited by 158
Decque, A., Joffre, O., Magalhaes, J. G., Cossec, J.-C., Blecher-Gonen, R., Lapaquette, P., Silvin, A., Manel, N., Joubert, P.-E., Seeler, J.-S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3342 · Cited by 158
Self-citationLiu, B., Yang, Y., Chernishof, V., Loo, R. R. O., Jang, H., Tahk, S., Yang, R., Mink, S. R., Shultz, D. B., Bellone, C. J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.056 · Cited by 156
Bawa‐Khalfe, T., & Yeh, E. T. H. (2010) · Genes & Cancer · doi:10.1177/1947601910382555 · Cited by 155
Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis
Kim, J. H., Choi, H. J., Kim, B., Kim, M. H., Lee, J. M., Kim, I. S., Lee, M. H., Choi, S. J., Kim, K. I., Kim, S., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1415 · Cited by 154
Negative Regulation of NF-κB Signaling by PIAS1
Liu, B., Yang, R., Wong, K. A., Getman, C., Stein, N., Teitell, M. A., Cheng, G., Wu, H., & Shuai, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1113-1123.2005 · Cited by 153
The Utility of Paradoxical Components in Biological Circuits
Hart, Y., & Alon, U. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.004 · Cited by 151
Long, J., Zuo, D., & Park, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504477200 · Cited by 151
The type I TGF-β receptor is covalently modified and regulated by sumoylation
Kang, J. S., Saunier, E. F., Akhurst, R. J., & Derynck, R. (2008) · Nature Cell Biology · doi:10.1038/ncb1728 · Cited by 151
Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.
McDoniels-Silvers, A. L., Nimri, C. F., Stoner, G. D., Lubet, R. A., & You, M. (2002) · PubMed · Cited by 150
Shao, R., Zhang, F.-P., Tian, F., Anders Friberg, P., Wang, X., Sjöland, H., & Billig, H. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.079 · Cited by 149
SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage
Hendriks, I. A., Treffers, L. W., Vries, M. V., Olsen, J. V., & Vertegaal, A. C. O. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.033 · Cited by 141
Neyret‐Kahn, H., Benhamed, M., Ye, T., Gras, S. L., Cossec, J., Lapaquette, P., Bischof, O., Ouspenskaia, M. V., Dasso, M., Seeler, J.-S., et al. (2013) · Genome Research · doi:10.1101/gr.154872.113 · Cited by 140
Self-citationYang, Y., Xia, F., Hermance, N. M., Mabb, A. M., Simonson, S. J. S., Morrissey, S., Gandhi, P., Munson, M., Miyamoto, S., & Kelliher, M. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01139-10 · Cited by 140
Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure
Kho, C., Lee, A., Jeong, D., Oh, J. G., Gorski, P. A., Fish, K. M., Sánchez, R., DeVita, R. J., Christensen, G., Dahl, R. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8229 · Cited by 137
Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer
Li, P., Yu, X., Ge, K., Melamed, J., Roeder, R. G., & Wang, Z. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64422-7 · Cited by 137
SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression
Bellail, A. C., Olson, J. J., & Hao, C. (2014) · Nature Communications · doi:10.1038/ncomms5234 · Cited by 135
Al-Khodairy, F. M., Enoch, T., Hagan, I., & Carr, A. M. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.2.475 · Cited by 134
The Ligase PIAS1 Restricts Natural Regulatory T Cell Differentiation by Epigenetic Repression
Liu, B., Tahk, S., Yee, K. M., Fan, G., & Shuai, K. (2010) · Science · doi:10.1126/science.1193787 · Cited by 134
The Nuclear Receptor Interaction Domain of GRIP1 Is Modulated by Covalent Attachment of SUMO-1
Kotaja, N., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204768200 · Cited by 130
Driscoll, J. J., Pelluru, D., Lefkimmiatis, K., Fulciniti, M., PRABHALA, R. H., Greipp, P. R., Barlogie, B., Tai, Y., Anderson, K. C., Shaughnessy, J. D., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211045 · Cited by 129
Ikaros SUMOylation: Switching Out of Repression
Arco, P. G., Koipally, J., & Georgopoulos, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2688-2697.2005 · Cited by 129
Wu, S., & Chiang, C. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.83 · Cited by 125
MicroRNA-mediated Regulation of Ubc9 Expression in Cancer Cells
Wu, F., Zhu, S., Ding, Y., Beck, W. T., & Mo, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0820 · Cited by 123
The SUMO E3-ligase PIAS1 Regulates the Tumor Suppressor PML and Its Oncogenic Counterpart PML-RARA
Rabellino, A., Carter, B., Konstantinidou, G., Wu, S.-Y., Rimessi, A., Byers, L. A., Heymach, J. V., Girard, L., Chiang, C., Teruya‐Feldstein, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3159 · Cited by 122
Han, Y. Y., Huang, C., Sun, X., Xiang, B., Wang, M., Yeh, E. T. H., Chen, Y., Li, H., Shi, G., Cang, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071431 · Cited by 121
Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells
Piret, B., & Piette, J. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4242 · Cited by 121
Wrestling with stress: Roles of protein SUMOylation and deSUMOylation in cell stress response
Guo, C., & Henley, J. M. (2014) · IUBMB Life · doi:10.1002/iub.1244 · Cited by 116
Global SUMOylation on active chromatin is an acute heat stress response restricting transcription
Niskanen, E. A., Malinen, M., Sutinen, P., Toropainen, S., Paakinaho, V., Vihervaara, A., Joutsen, J., Kaikkonen, M. U., Sistonen, L., & Palvimo, J. J. (2015) · Genome biology · doi:10.1186/s13059-015-0717-y · Cited by 115
Daxx Mediates the Small Ubiquitin-like Modifier-dependent Transcriptional Repression of Smad4
Chang, C., Lin, D.-Y., Fang, H.-I., Chen, R., & Shih, H.-M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409161200 · Cited by 114
Jacques, C., Baris, O. R., Mirebeau‐Prunier, D., Savagner, F., Rodien, P., Rohmer, V., Franc, B., Guyétant, S., Malthièry, Y., & Reynier, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1337 · Cited by 110
Bossis, G., Sarry, J., Kifagi, C., Ristic, M., Saland, E., Vergez, F., Salem, T., Boutzen, H., Baik, H., Brockly, F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.016 · Cited by 110
Expression of SUMO-2/3 Induced Senescence through p53- and pRB-mediated Pathways
Li, T., Santockyte, R., Shen, R., Tekle, E., Wang, G., Yang, D. C. H., & Chock, P. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608236200 · Cited by 109
Stielow, B., Sapetschnig, A., Krüger, I., Kunert, N., Brehm, A., Boutros, M., & Suske, G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.032 · Cited by 109
González‐Prieto, R., Cuijpers, S. A. G., Kumar, R., Hendriks, I. A., & Vertegaal, A. C. O. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1040965 · Cited by 108
Spectomycin B1 as a Novel SUMOylation Inhibitor That Directly Binds to SUMO E2
Hirohama, M., Kumar, A., Fukuda, I., Matsuoka, S., Igarashi, Y., Saitoh, H., Takagi, M., Shin‐ya, K., Honda, K., Kondoh, Y., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400630z · Cited by 108
Renner, F., Moreno, R., & Schmitz, M. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.018 · Cited by 104
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma
Höllein, A., Fallahi, M., Schoeffmann, S., Steidle, S., Schaub, F. X., Rudelius, M., Laitinen, I., Nilsson, L. M., Goga, A., Peschel, C., et al. (2014) · Blood · doi:10.1182/blood-2014-06-584524 · Cited by 102
Negative Regulation of TLR Inflammatory Signaling by the SUMO-deconjugating Enzyme SENP6
Liu, X., Chen, W., Wang, Q., Li, L., & Wang, C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003480 · Cited by 102
Ledl, A., Schmidt, D., & Müller, S. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208539 · Cited by 101
Advances in the development of SUMO specific protease (SENP) inhibitors
Kumar, A., & Zhang, K. Y. J. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.03.001 · Cited by 99
Kim, Y. S., Nagy, K. J., Keyser, S. G. L., & Schneekloth, J. S. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.04.001 · Cited by 98
Paakinaho, V., Kaikkonen, S., Makkonen, H., Beneš, V., & Palvimo, J. J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1033 · Cited by 98
Proteotoxic stress reprograms the chromatin landscape of SUMO modification
Seifert, A., Schofield, P. G., Barton, G. J., & Hay, R. T. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2213 · Cited by 97
SUMO functions in constitutive transcription and during activation of inducible genes in yeastPreprint
Rosonina, E., Duncan, S. M., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1917910 · Cited by 97
SUMO‐modified Sp3 represses transcription by provoking local heterochromatic gene silencing
Stielow, B., Sapetschnig, A., Wink, C., Krüger, I., & Suske, G. (2008) · EMBO Reports · doi:10.1038/embor.2008.127 · Cited by 94
Wuerzberger‐Davis, S. M., Nakamura, Y., Seufzer, B. J., & Miyamoto, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209815 · Cited by 90
Cheng, C. Y., Chu, C., Hsu, H.-W., Hsu, F.-R., Tang, C. Y., Wang, W., Kung, H.-J., & Chang, P. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s1-s1 · Cited by 89
Moschos, S. J., Smith, A. P., Mandić, M., Athanassiou, C., Watson-Hurst, K., Jukic, D. M., Edington, H. D. J., Kirkwood, J. M., & Becker, D. (2007) · Oncogene · doi:10.1038/sj.onc.1210216 · Cited by 88
Sun, L., Li, H., Chen, J., Iwasaki, Y., Kubota, T., Matsuoka, M., Shen, A., Chen, Q., & Xu, Y. (2013) · Journal of Cell Science · doi:10.1242/jcs.127381 · Cited by 88
Tomasi, M. L., Tomasi, I., Ramani, K., Pascale, R. M., Xu, J., Giordano, P., Mato, J. M., & Lu, S. C.-L. (2012) · Hepatology · doi:10.1002/hep.25701 · Cited by 86
Bawa‐Khalfe, T., Cheng, J., Wang, Z., & Yeh, E. T. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706978200 · Cited by 86
Xu, Y., Zuo, Y., Zhang, H., Kang, X., Fei, Y., Yi, Z., Liu, M., Yeh, E. T. H., Chen, G., & Cheng, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164236 · Cited by 86
Imoto, S., Sugiyama, K., Muromoto, R., Sato, N., Yamamoto, T., & Matsuda, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304961200 · Cited by 85
Tahk, S., Liu, B., Chernishof, V., Wong, K. A., Wu, H., & Shuai, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701877104 · Cited by 84
Lee, M. H., Mabb, A. M., Gill, G., Yeh, E. T. H., & Miyamoto, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.017 · Cited by 84
Regulation of p53 family members by the ubiquitin-like SUMO system
Stehmeier, P., & Muller, S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.002 · Cited by 83
Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response
Hsieh, Y.-L., Kuo, H.-Y., Chang, C., Naik, M. T., Liao, P.-H., Ho, C.-C., Huang, T.-C., Jeng, J., Hsu, P., Tsai, M., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.5 · Cited by 83
Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9
Yu, B., Swatkoski, S., Holly, A. J., Lee, L. C., Giroux, V., Lee, C.-S., Hsu, D. J., Smith, J. L., Yuen, G., Yue, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415569112 · Cited by 82
PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21
Hoefer, J., Schäfer, G., Klocker, H., Erb, H. H. H., Mills, I. G., Hengst, L., Puhr, M., & Čulig, Z. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.026 · Cited by 82
Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification
Cai, Q., Verma, S. C., Kumar, P., Ma, M., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009720 · Cited by 80
Ubc9 Sumoylation Controls SUMO Chain Formation and Meiotic Synapsis in Saccharomyces cerevisiae
Klug, H., Xaver, M., Chaugule, V. K., Koidl, S., Mittler, G., Klein, F., & Pichler, A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.03.027 · Cited by 79
Chromatin modification by SUMO-1 stimulates the promoters of translation machinery genes
Liu, H.-W., Zhang, J., Heine, G. F., Arora, M., Özer, H. G., Onti-Srinivasan, R., Huang, K., & Parvin, J. D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks819 · Cited by 78
Yates, K. E., Korbel, G. A., Shtutman, M., Roninson, I. B., & DiMaio, D. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00411.x · Cited by 77
Kerriamycin B inhibits protein SUMOylation
Fukuda, I., Ito, A., Uramoto, M., Saitoh, H., Kawasaki, H., Osada, H., & Yoshida, M. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2009.10 · Cited by 75
Role of the fission yeast SUMO E3 ligase Pli1p in centromere and telomere maintenance
Xhemalçe, B., Seeler, J.-S., Thon, G., Dejean, A., & Arcangioli, B. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600394 · Cited by 74
Self-citationGlobal analysis of SUMO chain function reveals multiple roles in chromatin regulation
Srikumar, T., Lewicki, M. C., Costanzo, M., Tkach, J. M., van Bakel, H., Tsui, K., Johnson, E. S., Brown, G. W., Andrews, B., Boone, C. M., et al. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201210019 · Cited by 73
Brems-Eskildsen, A. S., Zieger, K., Toldbod, H., Holcomb, C. L., Higuchi, R., Mansilla, F., Munksgaard, P. P., Borre, M., Orntoft, T. F., & Dyrskjøt, L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-646 · Cited by 72
Heterologous SUMO-2/3-Ubiquitin Chains Optimize IκBα Degradation and NF-κB Activity
Aillet, F., Lopitz‐Otsoa, F., Egaña, I., Hjerpe, R., Fraser, P. E., Hay, R. T., Rodríguez, M. S., & Lang, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051672 · Cited by 72
SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination
Lee, M. H., Lee, S. W., Lee, E. J., Choi, S. J., Chung, S. S., Lee, J. I., Cho, J. M., Seol, J. H., Baek, S. H., Kim, K. I., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1512 · Cited by 71
Bawa‐Khalfe, T., Lu, L., Zuo, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209378109 · Cited by 71
NF-κB Repression by PIAS3 Mediated RelA SUMOylation
Liu, Y., Bridges, R. G., Wortham, A. M., & Kulesz-Martin, M. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037636 · Cited by 66
Tempé, D., Vivès, É., Brockly, F., Brooks, H., de Rossi, S., Piechaczyk, M., & Bossis, G. (2013) · Oncogene · doi:10.1038/onc.2013.4 · Cited by 66
Shima, H., Suzuki, H., Sun, J., Kono, K., Shi, L., Kinomura, A., Horikoshi, Y., Ikura, T., Ikura, M., Kanaar, R., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.133744 · Cited by 66
Yang, W., Wang, L., Röhn, G., Pearlstein, R. D., Ali‐Osman, F., Pan, H., Goldbrunner, R., Krantz, M. S., Harms, C., & Paschen, W. (2012) · Cancer Science · doi:10.1111/cas.12047 · Cited by 63
Ren, Y.-H., Liu, K.-J., Wang, M., Yu, Y.-N., Yang, K., Chen, Q., Yu, B., Wang, W., Li, Q.-W., Wang, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2197 · Cited by 62
Heat shock induces a massive but differential inactivation of SUMO-specific proteases
Pinto, M. P., Carvalho, A. F., Grou, C. P. O., Rodríguez-Borges, J. E., Sá-Miranda, C., & Azevedo, J. E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.010 · Cited by 62
Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication
Şahin, U., Ferhi, O., Carnec, X., Zamborlini, A., Pérès, L., Jollivet, F., Vitaliano-Prunier, A., de Thé, H., & Lallemand-Breitenbach, V. (2014) · Nature Communications · doi:10.1038/ncomms5187 · Cited by 62
A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2
Borkent, M., Bennett, B. D., Lackford, B. L., Bar‐Nur, O., Brumbaugh, J., Wang, L., Du, Y., Fargo, D. C., Apostolou, E., Cheloufi, S., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.02.004 · Cited by 59
Liu, X., Xu, Y., Pang, Z., Guo, F., Qin, Q., Yin, T., Sang, Y., Feng, C., Li, X., Jiang, L., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0164-y · Cited by 57
Wei, J., Costa, C., Ding, Y., Zou, Z., Yu, L., Sánchez, J. J., Qian, X., Chen, H., Giménez-Capitán, A. A., Meng, F., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr326 · Cited by 57
SUMOylation in Control of Accurate Chromosome Segregation during Mitosis
Wan, J., Subramonian, D., & Zhang, X. D. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312802430563 · Cited by 56
Shayeghi, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.6.1162 · Cited by 56
SUMOylated SoxE factors recruit Grg4 and function as transcriptional repressors in the neural crest
Lee, P., Taylor, K. M., Nordin, K., Prasad, M. S., Lander, R. M., & LaBonne, C. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201204161 · Cited by 53
A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity
Inamura, K., Shimoji, T., Ninomiya, H., Hiramatsu, M., Okui, M., Satoh, Y., Okumura, S., Nakagawa, K., Noda, T., Fukayama, M., et al. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.019 · Cited by 52
microRNA-214-mediated UBC9 expression in glioma
Zhao, Z., Tan, X., Zhao, A.-N., Zhu, L., Yin, B., Yuan, J., Qiang, B., & Peng, X. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.11.097 · Cited by 51
Netherton, S. J., & Bonni, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013971 · Cited by 50
Phosphorylation of Ubc9 by Cdk1 Enhances SUMOylation Activity
Su, Y.-F., Yang, T.-H., Huang, H., Liu, L. F., & Hwang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034250 · Cited by 50
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation
Licciardello, M. P., Müllner, M. K., Dürnberger, G., Kerzendorfer, C., Boidol, B., Jessen‐Trefzer, C., Sdelci, S., Berg, T., Penz, T., Schuster, M. K., et al. (2014) · Oncogene · doi:10.1038/onc.2014.319 · Cited by 49
β-catenin SUMOylation is involved in the dysregulated proliferation of myeloma cells.
Huang, H., Zhou, L., Fu, W., Zhang, C.-Y., Jiang, H., Du, J., & Hou, J. Q. (2015) · Europe PMC (PubMed Central) · Cited by 48
Xu, J., Sun, H., Xiao, F., Wang, H., Yang, Y., Wang, L., Wang, L., Gao, C., Guo, Z., Wu, C.-T., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.047 · Cited by 47
TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling
Fattet, L., Ay, A., Bonneau, B., Jallades, L., Mikaélian, I., Treilleux, I., Gillet, G., Hesling, C., & Rimokh, R. (2013) · Journal of Cell Science · doi:10.1242/jcs.126748 · Cited by 47
Ma, C., Wu, B., Huang, X., Yuan, Z., Nong, K., Dong, B., Bai, Y., Zhu, H., Wang, W., & Ai, K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2598-1 · Cited by 47
Chien, W., Lee, K. L., Ding, L., Wuensche, P., Kato, H., Doan, N., Poellinger, L., Said, J. W., & Koeffler, H. P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.531 · Cited by 43
Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation
Sun, Z., Hu, S., Luo, Q., Ye, D., Hu, D., & Chen, F. (2013) · Oncology Reports · doi:10.3892/or.2013.2318 · Cited by 43
A Novel Mechanism for SUMO System Control: Regulated Ulp1 Nucleolar Sequestration
Sydorskyy, Y., Srikumar, T., Jeram, S. M., Wheaton, S., Vizeacoumar, F. J., Makhnevych, T., Chong, Y. T., Gingras, A., & Raught, B. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00335-10 · Cited by 43
Soustelle, C., Vernis, L., Fréon, K., Reynaud-Angelin, A., Chanet, R., Fabre, F., & Heude, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5130-5143.2004 · Cited by 41
PIAS1 Regulates Breast Tumorigenesis through Selective Epigenetic Gene Silencing
Liu, B., Tahk, S., Yee, K. M., Yang, R., Yang, Y., Mackie, R., Hsu, C., Chernishof, V., O’Brien, N. A., Jin, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089464 · Cited by 40
SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence
Wang, X. D., Lapi, E., Sullivan, A., Ratnayaka, I., Goldin, R. D., Hay, R. T., & Lü, X. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.101 · Cited by 40
Substantially reduced expression of PIAS1 is associated with colon cancer development
Coppola, D., Parikh, V., Boulware, D. C., & Blanck, G. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0570-z · Cited by 39
Importance of PIKKs in NF-κB activation by genotoxic stress
Sabatel, H., Pirlot, C., Piette, J. G., & Habraken, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.105 · Cited by 39
BLM SUMOylation regulates ssDNA accumulation at stalled replication forks
Ouyang, K. J., Yagle, M. K., Matunis, M. J., & Ellis, N. A. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00167 · Cited by 39
SENP5 mediates breast cancer invasion via a TGFβRI SUMOylation cascade
Cashman, R., Cohen, H., Ben‐Hamo, R., Zilberberg, A., & Efroni, S. (2014) · Oncotarget · doi:10.18632/oncotarget.1783 · Cited by 38
Chang, P., Cheng, C.-Y., Campbell, M., Yang, Y.-C., Hsu, H.-W., Chang, T.-Y., Chu, C., Lee, Y.-W., Hung, C.-L., Lai, S.-M., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-824 · Cited by 37
Ikeuchi, Y., Dadakhujaev, S., Chandhoke, A. S., Huynh, M., Oldenborg, A., Ikeuchi, M., Deng, L.-L., Bennett, E. J., Harper, J. W., Bonni, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575878 · Cited by 36
Mukherjee, S., Cruz-Rodríguez, O., Bolton, E. C., & Iñiguez-Lluhí, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.395210 · Cited by 33
Starting and stopping SUMOylation: What regulates the regulator?
Watts, F. Z. (2013) · Chromosoma · doi:10.1007/s00412-013-0422-0 · Cited by 32
Veltman, I. M., Vreede, L., Cheng, J., Looijenga, L. H. J., Janssen, B., Schoenmakers, E., Yeh, E. T. H., & van Kessel, A. G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi200 · Cited by 32
Ding, B., Sun, Y., & Huang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301523 · Cited by 31
Over-Expression of Small Ubiquitin-Related Modifier-1 and Sumoylated p53 in Colon Cancer
Zhang, H., Kuai, X., Ji, Z., Li, Z., & Shi, R. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9612-x · Cited by 30
Posttranslational control of telomere maintenance and the telomere damage response
Peuscher, M. H., & Jacobs, J. J. L. (2012) · Cell Cycle · doi:10.4161/cc.19847 · Cited by 28
Regulation of germ cell function by SUMOylation
Rodriguez, A., & Pangas, S. A. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2286-5 · Cited by 26
Li, T., Huang, S., Dong, M., Gui, Y., & Wu, D. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.03.007 · Cited by 25
SUMO-activating SAE1 transcription is positively regulated by Myc.
Amente, S., Lavadera, M. L., Palo, G. D., & Majello, B. (2012) · Europe PMC (PubMed Central) · Cited by 24
At the crossroads of SUMO and NF-kappaB.
Kracklauer, M. P., & Schmidt, C. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-39 · Cited by 23
Human factors and pathways essential for mediating epigenetic gene silencing
Poleshko, A. S., Kossenkov, A. V., Shalginskikh, N., Pecherskaya, A., Pecherskaya, A., Einarson, M. B., Einarson, M. B., Skalka, A. M., Skalka, A. M., Katz, R. A., et al. (2014) · Epigenetics · doi:10.4161/epi.32088 · Cited by 22
Synowiec, E., Krupa, R., Morawiec, Z., Wasylecka, M., Dziki, Ł. A., Morawiec, J., Błasiak, J., & Woźniak, K. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.09.002 · Cited by 22
Buscà, R., Berra, E., Pouysségur, J., & Ballotti, R. (2006) · médecine/sciences · doi:10.1051/medsci/200622110 · Cited by 19
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Cited by
The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy
Kwon, Y. T., & Ciechanover, A. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.09.002 · Cited by 817
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
Signalling mechanisms and cellular functions of SUMO
Vertegaal, A. C. O. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00500-y · Cited by 376
The post-translational modification, SUMOylation, and cancer (Review)
Han, Z.-J., Feng, Y.-H., Gu, B.-H., Li, Y.-M., & Chen, H. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4280 · Cited by 334
Ubiquitin signaling and autophagy
Grumati, P., & Dikic, I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000117 · Cited by 327
Metadata
- Authors
- Seeler, J.-S., & Dejean, A.
- Venue
- Nature Reviews Cancer
- Published
- 2017-01-30
- Volume
- 17
- Issue
- 3
- Pages
- 184-197
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2581489880
- Cited by
- 429
- References
- 199
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.